Focus
Robert Califf
Senate Panel Questions FDA Nominee on Drug Prices, Approvals
President Barack Obama’s nominee to lead the Food and Drug Administration defended his record Tuesday as senators pressed him about rising drug prices, slow approval times for new drugs and his ties to the pharmaceutical industry.
